Free Trial
ASX:CYP

Cynata Therapeutics (CYP) Stock Price, News & Analysis

About Cynata Therapeutics Stock (ASX:CYP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
159,853 shs
Average Volume
N/A
Market Capitalization
A$57.60 million
P/E Ratio
N/A
Dividend Yield
13.95%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cynata Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CYP Stock News Headlines

Cynata Therapeutics Ltd (51S.SG) - Yahoo Finance
Jeff Brown: My shocking meeting in Washington, D.C.
President Trump’s “Project MAFA” After a shocking discovery in Washington D.C., Jeff Brown is putting out an urgent broadcast on Wednesday, July 16, at 8 p.m. ET to cover the president’s bold new initiative. Get a look inside Trump’s genius masterplan to create a “new” gold standard, smash the U.S. debt, and kick off a Golden Century before July 25.
See More Headlines

CYP Stock Analysis - Frequently Asked Questions

Cynata Therapeutics Limited (ASX:CYP) released its earnings results on Wednesday, February, 27th. The company reported ($0.03) earnings per share for the quarter, hitting the consensus estimate of ($0.03). Cynata Therapeutics had a negative trailing twelve-month return on equity of 100.01% and a negative net margin of 420.82%.

Company Calendar

Last Earnings
2/27/2019
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:CYP
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$9.74 million
Net Margins
-420.82%
Pretax Margin
N/A
Return on Equity
-100.01%
Return on Assets
-46.70%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.58
Quick Ratio
9.23

Sales & Book Value

Annual Sales
A$2.32 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
11.93
Book Value
A$0.04 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
180,680,000
Free Float
N/A
Market Cap
A$57.60 million
Optionable
Not Optionable
Beta
0.93
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ASX:CYP) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners